Sprint Bioscience AB (publ) (STO:SPRINT)

Sprint Bioscience AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	25.06	49.93	29.49	70.64	27.08
Cash & Short-Term Investments	25.06	49.93	29.49	70.64	27.08
Cash Growth	-49.82%	69.31%	-58.25%	160.92%	223.09%
Accounts Receivable	-	0.8	0.01	0.02	1.33
Other Receivables	12.19	7.14	5.38	5.28	3.06
Receivables	12.19	7.94	5.39	5.29	4.39
Prepaid Expenses	-	-	-	-	0.81
Total Current Assets	37.24	57.87	34.88	75.94	32.27
Property, Plant & Equipment	4.72	4.38	2.37	2.99	0.87
Long-Term Investments	0.05	0.05	0.05	0.05	0.05
Other Long-Term Assets	0.05	0.08	0.12	0.16	0.2
Total Assets	42.06	62.38	37.42	79.14	33.4
Accounts Payable	5.44	5.71	3.73	2.92	3.4
Accrued Expenses	4.7	3.37	4.43	4.54	7.52
Short-Term Debt	-	-	-	-	10
Current Unearned Revenue	11.23	12.32	-	-	-
Other Current Liabilities	11.42	13.21	1.07	1.22	3.33
Total Current Liabilities	32.78	34.6	9.23	8.68	24.26
Total Liabilities	32.78	34.6	9.23	8.68	24.26
Common Stock	6.98	6.98	6.98	3.98	2.12
Additional Paid-In Capital	273.67	273.9	273.87	258.97	174.44
Retained Earnings	-271.38	-253.1	-252.67	-192.5	-167.41
Shareholders' Equity	9.27	27.77	28.19	70.45	9.14
Total Liabilities & Equity	42.06	62.38	37.42	79.14	33.4
Total Debt	-	-	-	-	10
Net Cash (Debt)	25.06	49.93	29.49	70.64	17.08
Net Cash Growth	-49.82%	69.31%	-58.25%	313.73%	103.76%
Net Cash Per Share	0.36	0.72	0.70	2.45	1.02
Filing Date Shares Outstanding	69.82	69.82	69.8	39.84	21.21
Total Common Shares Outstanding	69.82	69.82	69.8	39.84	21.21
Working Capital	4.46	23.27	25.65	67.25	8.02
Book Value Per Share	0.13	0.40	0.40	1.77	0.43
Tangible Book Value	9.27	27.77	28.19	70.45	9.14
Tangible Book Value Per Share	0.13	0.40	0.40	1.77	0.43
Machinery	10.96	9.66	7.21	7.21	4.5

Source: S&P Global Market Intelligence. Standard template. Financial Sources.